Real world evidence

Pharmaceutical and Life Sciences Real World Evidence Market Outlook 2021-2030: Comparison of Randomized Clinical Trials and Real World Evidence

Retrieved on: 
Tuesday, May 4, 2021
Clinical research, Health sciences, Health, Design of experiments, Medical research, Evidence, Health informatics, Randomized controlled trial, Real world evidence, Clinical trial

In fact, on an average, the journey from establishment of initial proof-of-concept to product launch, takes around 10-12 years.

Key Points: 
  • In fact, on an average, the journey from establishment of initial proof-of-concept to product launch, takes around 10-12 years.
  • Moreover, regulatory approval is dependent on the results of randomized clinical trials (RCTs), which are estimated to account for a staggering 40% of the pharmaceutical industry\'s budget in the US.
  • Presently, big pharmaceutical companies are estimated to spend nearly USD 20 million on an annual basis, on generating real world evidence to support their respective clinical development programs.
  • The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.\nThe USD 4.5 billion (by 2030) financial opportunity within the real world evidence market has been analyzed across the following segments:\n'

Global Real World Evidence (RWE) Solutions [Datasets, EMR, Services] Markets, 2020-2027

Retrieved on: 
Tuesday, December 29, 2020
Pharmaceutical industry, Life sciences, Health sciences, Clinical research, Drug development, Drug discovery, Real world evidence, Medical device, Health

DUBLIN, Dec. 29, 2020 /PRNewswire/ -- The "Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 29, 2020 /PRNewswire/ -- The "Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027.
  • Based on application, the drug development and approvals segment is estimated to account for the largest share of the market in 2020.
  • In terms of end-users of real-world evidence solutions, pharmaceutical, biotech & medical device companies tend to use them extensively.

Global Real World Evidence (RWE) Solutions Markets, 2020-2027: Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development - ResearchAndMarkets.com

Retrieved on: 
Friday, December 18, 2020
General Health, Pharmaceutical, Health, Pharmaceutical industry, Life sciences, Health sciences, Clinical research, Drug development, Drug discovery, Real world evidence, Medical device, Health

The "Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Real World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development and Approvals (Oncology, Neurology, Immunology), Market Access, Medical Device Development], End User - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The real-world evidence solutions market is expected to grow at a CAGR of 16.5% from 2020 to 2027 to reach USD 3.13 billion by 2027.
  • Based on application, the drug development and approvals segment is estimated to account for the largest share of the market in 2020.
  • In terms of end-users of real-world evidence solutions, pharmaceutical, biotech & medical device companies tend to use them extensively.

Market Tracking and Real World Drug Performance Analysis Helps a Pharmaceutical Firm Increase Market Share | Get in Touch to Learn More About Quantzig’s Real World Evidence Analytics Capabilities

Retrieved on: 
Wednesday, August 12, 2020
Health, Data management, Pharmaceutical, Technology, Oncology, Articles, Business intelligence, Business, Formal sciences, Analytics, Big data, Real world evidence, Business analytics, Prescriptive analytics

View the full release here: https://www.businesswire.com/news/home/20200812005314/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200812005314/en/
    As experts in the field of real world data analysis, Quantzig offers real world evidence analytics solutions that help healthcare, pharma, and life science industries make the most of the available real world data sets.
  • The primary objective of real world evidence analytics was to provide clinical evidence regarding the usage and potential benefits or risks of a drug derived from the analysis of real world data.
  • Today, pharmaceutical manufacturing companies are investing in real world evidence analytics to gain insights into untapped opportunities.
  • Get your FREE customized proposal to know how Quantzigs real world evidence analytics services enable faster, better-informed decisions through a holistic and consistent assessment of real world data impacting business growth.

How Real World Evidence Analytics Can Accelerate COVID-19 Drug Discovery and Vaccine Trials | Quantzig

Retrieved on: 
Thursday, July 23, 2020
Health, Pharmaceutical, Articles, Health, Business intelligence, Formal sciences, Analytics, Big data, Real world evidence, Adherence, Learning analytics, Prescriptive analytics

Quantzigs real world evidence analytics solutions provide comprehensive insights on treatment pathways, patient adherence, disease progression, pricing levels and market access, drug safety, and patient engagement.

Key Points: 
  • Quantzigs real world evidence analytics solutions provide comprehensive insights on treatment pathways, patient adherence, disease progression, pricing levels and market access, drug safety, and patient engagement.
  • Connect with our experts to gain limited-time complimentary access to our real world evidence analytics platform .
  • Many such factors have shed light on the importance of leveraging real world evidence analytics to gain critical insights that can accelerate drug discovery.
  • The rise in the availability of real world data has shed light on the importance of real world evidence analytics in improving healthcare outcomes.

Real World Evidence Analytics: Quantzig Helps its Clients Leverage Real World Data to Accelerate Next-gen Pharma R&D

Retrieved on: 
Tuesday, May 19, 2020
Health, Data management, Pharmaceutical, Practice Management, Technology, Articles, Business intelligence, Economy, Formal sciences, Business, Big data, Analytics, Real world evidence, Web analytics, Prescriptive analytics

According to Quantzigs real world evidence analytics experts, Our real world evidence analytics solutions are specifically designed to help healthcare organizations evaluate the drug treatment efficacy and cost-effectiveness of therapies to complement clinical trial outcomes using real world data sets.

Key Points: 
  • According to Quantzigs real world evidence analytics experts, Our real world evidence analytics solutions are specifically designed to help healthcare organizations evaluate the drug treatment efficacy and cost-effectiveness of therapies to complement clinical trial outcomes using real world data sets.
  • Real world data analytics also enables joint analyses of clinical and pre-clinical data from disparate sources, leading to transparency and better visibility into the drug discovery and pharma R&D processes.
  • Our real world evidence analytics solutions have helped leading pharma companies to accelerate R&D processes and drug development by turning real world data into actionable insights.
  • Talk to our analytics experts to learn how our expertise in real world evidence analytics can help you capture, access, and analyze all forms of real world data to extract maximum insights.

How Data Analytics in Clinical Trial is Changing the Dynamics of Pharma Industry | A Quantzig Success Story

Retrieved on: 
Monday, May 11, 2020
Technology, Pharmaceutical, Health, Data management, Articles, Business intelligence, Formal sciences, Analytics, Big data, Real world evidence, Prescriptive analytics

Over the past few years, companies in the healthcare industry have invested considerable resources in real world evidence (RWE) analytics.

Key Points: 
  • Over the past few years, companies in the healthcare industry have invested considerable resources in real world evidence (RWE) analytics.
  • Also, a few leading healthcare companies have broken new ground with their systematic rather than opportunistic approach to real world evidence analytics.
  • Quantzigs data analytics solutions are specifically designed to help healthcare organizations evaluate the drug treatment efficacy and cost-effectiveness of therapies.
  • Data analytics in healthcare help companies merge the databases from multiple sources, to filter out patients who do not meet the basic requirements, says a data analytics expert at Quantzig.

Genesis Research Announces the Appointment of New Board Member

Retrieved on: 
Monday, May 11, 2020
Musicians, Musical groups, Record labels, Health informatics, Health Economics, Clinical research, Evidence, Real world evidence, Pharmacoeconomics, Genesis, Draft:International Society for Pharmacoeconomics and Outcomes Research

A Charter Member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Chris served as ISPOR President in 2008-2009.

Key Points: 
  • A Charter Member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Chris served as ISPOR President in 2008-2009.
  • We are pleased to welcome Chris to our Board of Directors at this important next stage in Genesis Research's evolution," stated Steve Arikian, MD, Co-Founder & Chairman of the Board of Genesis Research.
  • Genesis Research is a value demonstration company, powered by Real World Evidence development serving the Life Sciences industry.
  • Genesis Research is a portfolio company of Rallyday Partners.

Real World Evidence Analytics is Turning Out to be a ‘Life Saver’ in Healthcare | Quantzig’s Recent Article Offers Unprecedented Insights on Its Benefits

Retrieved on: 
Monday, May 4, 2020
Health, Hospitals, Articles, Health, Clinical research, Health informatics, Evidence, Real world evidence, Health care, Prescriptive analytics, Patient participation

Real world evidence (RWE) is a great tool to ensure better patient outcomes and drug efficacy.

Key Points: 
  • Real world evidence (RWE) is a great tool to ensure better patient outcomes and drug efficacy.
  • Our real world evidence analytics experts can help you leverage analytics and embed algorithmic decision making in your business structure to drive better clinical outcomes.
  • Based on patient outcomes, real world evidence can also lay the foundation in establishing effective risk-sharing agreements between manufacturers, payers, and providers.
  • Providers and life sciences companies in the healthcare industry should seek out partners with robust clinical and financial healthcare databases to provide easier and quicker access to insights derived from real world evidence.

TFS Forms Partnership to Conduct a Global RWE Study on Covid-19 Pandemic

Retrieved on: 
Wednesday, April 1, 2020
Health, Clinical research, Articles, Evidence, Health informatics, Coronaviridae, Real world evidence, Coronavirus, Epidemiology, Clinical trial

(source: ohdsi.org)

Key Points: 
  • (source: ohdsi.org)
    TFS partners with IOMED on a recently approved local RWE study, "COVID-19 REAL".
  • Within this strategicpartnership, TFS will analyze data using the standardized tools provided by the OHDSI collaboration.
  • Coronavirus disease 2019 (COVID-19) pandemic has an urgent need for answering many questions regarding epidemiology and natural history of the disease.
  • Neus Valveny, TFS Operational Strategy Lead Real World Evidence, addresses the importance of real world evidence to complement clinical trial results.